-
1
-
-
84865194855
-
Implementation of proteomic biomarkers: Making it work
-
Mischak H, Ioannidis JP, Argiles A et al (2012) Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 42:1027–1036
-
(2012)
Eur J Clin Invest
, vol.42
, pp. 1027-1036
-
-
Mischak, H.1
Ioannidis, J.P.2
Argiles, A.3
-
2
-
-
84921806981
-
-
Qualification of novel methodologies for medicine development, Accessed 30 Sept
-
Qualification of novel methodologies for medicine development. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000319.jsp&mid=WC0b01ac0580022bb0#section2. Accessed 30 Sept 2013
-
(2013)
-
-
-
3
-
-
84921749197
-
-
EMA workshops on biomarkers, Accessed 30 Sept
-
EMA workshops on biomarkers. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2009/11/event_detail_000077.jsp&mid=WC0b01ac058004 d5c3.http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2009/11/event_detail_000082.jsp&mid=WC0b01ac058004d5c3. Accessed 30 Sept 2013
-
(2013)
-
-
-
4
-
-
79957618123
-
New pathway for qualifi cation of novel methodologies in the European Medicines Agency
-
Manolis E, Vamvakas S, Isaac M (2011) New pathway for qualifi cation of novel methodologies in the European Medicines Agency. Proteomics Clin Appl 5:248–255
-
(2011)
Proteomics Clin Appl
, vol.5
, pp. 248-255
-
-
Manolis, E.1
Vamvakas, S.2
Isaac, M.3
-
5
-
-
84921736665
-
-
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use concept paper on pharmacogenomic biomarker qualification: format and data standards
-
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use concept paper on pharmacogenomic biomarker qualification: format and data standards. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003863.pdf. Accessed 30 Sept 2013
-
-
-
-
6
-
-
84921794418
-
-
Guideline on clinical evaluation of diagnostic agents, Accessed 30 Sept
-
Guideline on clinical evaluation of diagnostic agents. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003580.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
-
7
-
-
84921788315
-
-
Reflection paper on pharmacogenomic samples, testing and data handling, Accessed 30 Sept
-
Reflection paper on pharmacogenomic samples, testing and data handling. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003864.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
-
8
-
-
84921726031
-
-
Reflection paper on co-development of pharmacogenomic biomarkers and assays in the context of drug development, Accessed 30 Sept
-
Reflection paper on co-development of pharmacogenomic biomarkers and assays in the context of drug development. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/07/WC500094445.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
-
9
-
-
84866737569
-
Personalized medicine using DNA biomarkers: A review
-
Ziegler A, Koch A, Krockenberger K et al (2012) Personalized medicine using DNA biomarkers: a review. Hum Genet 131:1627–1638
-
(2012)
Hum Genet
, vol.131
, pp. 1627-1638
-
-
Ziegler, A.1
Koch, A.2
Krockenberger, K.3
-
10
-
-
84921752954
-
-
ICH topic E 9 statistical principles for clinical trials, Accessed 30 Sept 2013
-
ICH topic E 9 statistical principles for clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002928.pdf. Accessed 30 Sept 2013
-
-
-
-
11
-
-
84921807611
-
-
Accessed 30 Sept
-
http://www.cdisc.org/. Accessed 30 Sept 2013
-
(2013)
-
-
-
12
-
-
84921745692
-
-
EMA points to consider on application with 1. meta-analysis; 2. one pivotal study, Accessed 30 Sept
-
EMA points to consider on application with 1. meta-analysis; 2. one pivotal study. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003657.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
-
13
-
-
84921771094
-
-
Reflection paper on risk based quality management in clinical trials, Accessed 30 Sept
-
Reflection paper on risk based quality management in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500110059.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
-
14
-
-
84921709446
-
-
Qualification opinion ILSI/HESI submission of novel renal biomarkers for toxicity, Accessed 30 Sept
-
Qualification opinion ILSI/HESI submission of novel renal biomarkers for toxicity. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/11/WC500099359.pdf. Accessed 30 Sept 2013
-
(2013)
-
-
|